![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-3873|7|3|187-194
ISSN: 1871-5303
Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.7, Iss.3, 2007-09, pp. : 187-194
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Probiotics in the Management of Crohn's disease and Ulcerative Colitis
Current Pharmaceutical Design, Vol. 20, Iss. 28, 2014-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis
By Serada Satoshi Fujimoto Minoru Terabe Fumitaka Iijima Hideki Shinzaki Shinichiro Matsuzaki Shinya Ohkawara Tomoharu Nezu Riichiro Nakajima Sachiko Kobayashi Taku Plevy Scott Eric Takehara Tetsuo Naka Tetsuji
Inflammatory Bowel Diseases, Vol. 18, Iss. 11, 2012-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Ufer Mike Hääsler Robert Jacobs Gunnar Haenisch Sierk Läächelt Sandra Faltraco Frank Sina Christian Rosenstiel Philip Nikolaus Susanna Schreiber Stefan Cascorbi Ingolf
Pharmacogenomics, Vol. 10, Iss. 12, 2009-12 ,pp. :